Indian drugmaker seeks to toss 'bloated' billion-dollar lawsuit over Covid vaccine candidate
A drug manufacturer is looking to end a suit brought on by a Seattle-based biotech.
Emcure Pharmaceuticals, a Pune, India-based manufacturer of generic drugs, is …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
